Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > MI Providers > Urologists

Dr. David A. Leavitt, MD

Accepting New Patients

(16 Ratings)

Specializes in: Urology (Urinary Tract Disease)

University of Michigan Medical School (2008)

Professional interests include: benign prostatic hyperplasia (enlarged prostate), kidney problems, men's health issues, and more.

2799 W. GRAND BOULEVARD
Detroit, MI 48202

(313) 916-2600

Dr. David A. Leavitt, MD is an urologist in Detroit, MI specializing in urology (urinary tract disease). He graduated from University of Michigan Medical School in 2008 and has 16 years of experience. Dr. David A. Leavitt, MD is affiliated with Henry Ford Health, Henry Ford West Bloomfield Hospital, Henry Ford Wyandotte Hospital, Henry Ford Hospital, Henry Ford Macomb Hospital - Clinton Township and Henry Ford Medical Group.

Office Locations

Address:

2799 W. GRAND BOULEVARD
Detroit, MI 48202

Address:

19401 HUBBARD DRIVE
Dearborn, MI 48126

Address:

6777 WEST MAPLE ROAD
West Bloomfield, MI 48322

Some issues Dr. David A. Leavitt, MD can help you with:

Benign Prostatic Hyperplasia (Enlarged Prostate)

Benign prostatic hyperplasia (BPH) is a noncancerous condition in which the prostate gland becomes enlarged. BPH affects about half of men between the ages of 50 and 60, and approximately 80% of men over 80. As the prostate grows in size, it can press down on the tube where urine flows out of the body (the urethra) and cause urinary problems.

Medication can relieve mild to moderate symptoms of BPH, such as frequent urination, incomplete bladder emptying, a weak urine stream, and straining while urinating. However, other forms of treatment may be more appropriate if an individual has pain with urination, frequent urinary tract infections, or is unable to urinate. The size of the prostate and the severity of their symptoms will determine the type of treatment they need. If the prostate is not very large, doctors will likely recommend a transurethral procedure. This minimally invasive technique involves the insertion of a scope into the urethra. The most common transurethral procedures for BPH are:

Transurethral incision of the prostate or TUIP, where the surgeon uses the scope to make small cuts in the area of the prostate that meets the bladder. These cuts will open up the pathway for urine and allow it to flow with more ease.
Transurethral needle ablation or TUNA, where needles are inserted through the scope and into the prostate. The needles use radiofrequency waves to destroy excess prostate tissue.
Laser prostate ablation, where lasers pass through the scope to melt away the part of the prostate causing urine blockage.
Transurethral resection of the prostate or TURP, where the inside of the prostate is trimmed and removed one tiny piece at a time using the scope.

If the prostate is too big for a transurethral procedure, an individual may need a simple prostatectomy, which can be done in one of three ways: laparoscopic, robotic, or open. During a laparoscopic simple prostatectomy, a surgeon makes several small incisions on the belly. Then they insert a long tube with a camera into one of the cuts and surgical instruments into the others. Using the camera to see inside the belly, they carefully removes the enlarged part of the prostate. Robotic simple prostatectomy uses the same techniques as the laparoscopic method, but the surgery is done with the help of a robot. For men with very large prostates, open simple prostatectomy may be the best treatment option. This surgery differs from the other approaches in that it requires a much larger incision.

Most transurethral treatments for BPH, like TUIP, TUNA, and laser prostate ablation, are done in the doctor's office or outpatient surgery center. TURP and simple prostatectomy, however, need to be performed in the hospital and require an average stay of one to three days. Patients should wait a week before doing any strenuous activities after a TUIP, TUNA, or laser prostate ablation, and about four to six weeks after a TURP or simple prostatectomy. Although these treatments improve BPH symptoms for most patients, it is important to be aware of the risks involved, such as urine control issues, tightening of the urethra, and erectile dysfunction.

Kidney Stones

Kidney stones are hard deposits that form in the kidneys, made up of minerals that are normally present in urine. They can vary in size, from as small as a grain of sand to as large as a nickel, occasionally even larger. Sometimes they lodge in the kidney, and sometimes they break free and make their way out through the urinary tract, which can be extremely painful.

Kidney stones can be smooth or jagged and are yellow to brown in color. They are mostly comprised of the minerals calcium, oxalate, and phosphorus. Examining the stones to see what they are made of can show what caused the stone to be formed in the first place. For example, a stone made of mostly calcium, which is the most common type, can happen any time the urine becomes too concentrated due to dehydration or a blockage in the kidney. A uric acid stone forms when acid levels in the urine get too high, usually due to excessive consumption of animal protein such as meat and fish. A struvite stone is a sign of certain infections, and a cystine stone can be due to a genetic disorder that raises the risk of kidney stones.

The most common symptom of kidney stones is pain, either in the back or lower abdomen, or severe pain when urinating. There may also be blood in the urine. Treatment for kidney stones depends on how large the stone is. Very small stones can pass out of the body on their own, and they do not require treatment other than drinking adequate water and taking pain killers. Larger stones need to be broken apart and removed. The main treatment options are:

Shock wave lithotripsy, which uses sound wave vibrations to break apart the stone
Percutaneous nephrolithotomy, or the use of a very tiny tool (like a wire inserted through the back) to break apart and remove the stone
Ureteroscopy, a thin tube inserted through the urethra and bladder to the stone, where tiny tools can grasp the stone and remove

People who have had one kidney stone are at risk of developing another. To reduce this risk, patients are given instructions specific to the type of stone they developed. Generally the instructions will include drinking more water to dilute the urine, but it may also involve lowering sodium intake or eating less meat.

hospital care	17
inpatient care	17

Hypertension	75
High Cholesterol	62
Stroke	0
Ischemic Heart Disease	75
Depression	0
Chronic Kidney Disease	75
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

doctor visit	28

**Gender**
Male	112
Female	40

**Ethnicity**
Non-Hispanic White	86
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	64
From 75 to 84	32
85 and over	22
Less than 65	34

Hypertension	75
High Cholesterol	57
Stroke	0
Ischemic Heart Disease	53
Depression	20
Chronic Kidney Disease	51
Asthma	18
Osteoperosis	0
Atrial Fibrilation	21
Heart Failure	30
Chronic Obstructive Pulmonary Disease	20
Diabetes	50
Dementia	14
Cancer	18

doctor visit	278
foreign body removal	12
laser treatment	16
lithotripsy (stone fragmentation)	17
minimally invasive procedures	54
stent placement (stenting)	16
urologic procedures	119

**Gender**
Male	152
Female	74

**Ethnicity**
Non-Hispanic White	138
Black	71
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	98
From 75 to 84	45
85 and over	30
Less than 65	53

Hypertension	73
High Cholesterol	52
Stroke	6
Ischemic Heart Disease	39
Depression	24
Chronic Kidney Disease	53
Asthma	17
Osteoperosis	0
Atrial Fibrilation	16
Heart Failure	22
Chronic Obstructive Pulmonary Disease	12
Diabetes	46
Dementia	18
Cancer	16

ablation	13
doctor visit	339
hospital care	32
inpatient care	32
laser treatment	31
lithotripsy (stone fragmentation)	18
minimally invasive procedures	65
stent placement (stenting)	17
urologic procedures	182

**Gender**
Male	211
Female	78

**Ethnicity**
Non-Hispanic White	185
Black	74
Hispanic	0
Asian	0
Other	14
Native American	0

**Age**
From 65 to 74	148
From 75 to 84	68
85 and over	28
Less than 65	45

Hypertension	75
High Cholesterol	51
Stroke	5
Ischemic Heart Disease	41
Depression	22
Chronic Kidney Disease	53
Asthma	9
Osteoperosis	6
Atrial Fibrilation	15
Heart Failure	23
Chronic Obstructive Pulmonary Disease	18
Diabetes	44
Dementia	17
Cancer	16

ablation	13
doctor visit	300
hospital care	15
inpatient care	15
laser treatment	35
lithotripsy (stone fragmentation)	22
minimally invasive procedures	64
stent placement (stenting)	21
urologic procedures	148

**Gender**
Male	206
Female	75

**Ethnicity**
Non-Hispanic White	187
Black	65
Hispanic	0
Asian	0
Other	14
Native American	0

**Age**
From 65 to 74	139
From 75 to 84	74
85 and over	28
Less than 65	40

Hypertension	72
High Cholesterol	57
Stroke	6
Ischemic Heart Disease	44
Depression	26
Chronic Kidney Disease	54
Asthma	9
Osteoperosis	5
Atrial Fibrilation	16
Heart Failure	23
Chronic Obstructive Pulmonary Disease	15
Diabetes	45
Dementia	15
Cancer	17

ablation	15
doctor visit	285
hospital care	63
inpatient care	63
laser treatment	36
lithotripsy (stone fragmentation)	21
minimally invasive procedures	84
stent placement (stenting)	41
urologic procedures	140

**Gender**
Male	197
Female	89

**Ethnicity**
Non-Hispanic White	180
Black	78
Hispanic	11
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	160
From 75 to 84	66
85 and over	25
Less than 65	35

Hypertension	72
High Cholesterol	58
Stroke	6
Ischemic Heart Disease	43
Depression	23
Chronic Kidney Disease	56
Asthma	7
Osteoperosis	7
Atrial Fibrilation	14
Heart Failure	27
Chronic Obstructive Pulmonary Disease	14
Diabetes	45
Dementia	15
Cancer	13

doctor visit	101
foreign body removal	13
laser treatment	18
lithotripsy (stone fragmentation)	19
minimally invasive procedures	57
stent placement (stenting)	35
urologic procedures	72

**Gender**
Male	124
Female	53

**Ethnicity**
Non-Hispanic White	120
Black	39
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	97
From 75 to 84	36
85 and over	16
Less than 65	28

Hypertension	71
High Cholesterol	55
Stroke	7
Ischemic Heart Disease	36
Depression	19
Chronic Kidney Disease	59
Asthma	10
Osteoperosis	0
Atrial Fibrilation	8
Heart Failure	21
Chronic Obstructive Pulmonary Disease	14
Diabetes	37
Dementia	16
Cancer	16

ablation	35
doctor visit	278
laser treatment	80
lithotripsy (stone fragmentation)	45
minimally invasive procedures	123
stent placement (stenting)	57
urologic procedures	176

Average Medicare Procedure Volume From 2014 - 2021

Volume of procedures performed by Dr. David A. Leavitt, MD for Medicare patients.

The highest averages for the top procedures that Dr. David A. Leavitt, MD treated as an urologist in Detroit, MI were urologic procedures, minimally invasive procedures, laser treatment and hospital care.

ablation	19
doctor visit	231
foreign body removal	12
hospital care	31
inpatient care	31
laser treatment	36
lithotripsy (stone fragmentation)	23
minimally invasive procedures	76
stent placement (stenting)	31
urologic procedures	141

Average Medicare Patient Data From 2014 - 2021

Information about Medicare patients treated by Dr. David A. Leavitt, MD.

**Gender**
Male	100
Female	40

**Ethnicity**
Black / African American	32
Asian / Pacific Islander	0
Non-Hispanic White	89
Native American / Alaskan Native	0
Hispanic	1
Other	2

**Age**
75 to 84	32
85 and over	14
Less than 65	23
65 to 74	70

Average of Total of Conditions of Medicare patients treated by Dr. David A. Leavitt, MD From 2014 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. David A. Leavitt, MD treated were hypertension, chronic kidney disease, high cholesterol and ischemic heart disease.

Hypertension	51
High Cholesterol	39
Stroke	3
Ischemic Heart Disease	33
Depression	13
Chronic Kidney Disease	40
Asthma	7
Osteoporosis	1
Heart Failure	14
Chronic Obstructive Pulmonary Disease	9
Diabetes	26
Atrial Fibrillation	9
Cancer	9
Dementia	9

Education & Training

Dr. David A. Leavitt, MD graduated from University of Michigan Medical School in 2008. He completed residency at University of Minnesota Affiliated Hospitals. He is certified by the American Board of Urology - Urology and has a state license in Michigan.

Medical School: University of Michigan Medical School (2008)

Residency: University of Minnesota Affiliated Hospitals (2009)

Board Certification: American Board of Urology - Urology

Licensed In: Michigan

Affiliations & Hospitals

Dr. David A. Leavitt, MD is associated with these hospitals and organizations:

Henry Ford Health

Henry Ford West Bloomfield Hospital

Henry Ford Wyandotte Hospital

Henry Ford Hospital

Henry Ford Macomb Hospital - Clinton Township

Henry Ford Medical Group

Ratings & Reviews

Dr. David A. Leavitt, MD has an exceptional overall rating with an average of 5.0 out of 5 stars based on 16 ratings. We collect ratings and reviews of Dr. David A. Leavitt, MD from all over the web to help you find the right in Detroit, MI.

Overall Rating

(16 Ratings)

Leave a Review

Reviews From Around The Web

Overall Rating: 5.0 2022-12-07